Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
BMC Cancer
|
July 2, 2020
Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
Sivan Shamai, Zach Rozenbaum, Ofer Merimsky, et al.
Journal of Thoracic Disease
|
April 16, 2026
Thoracoscopic lobectomy for early-stage non-small cell lung carcinoma: initial experience from a newly established Israeli center
Boris Giller, Sharbel Azzam, Nahum Nesher, et al.
Cancer Chemotherapy and Pharmacology
|
October 12, 2012
Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas
Rinat Bernstein-Molho, Yehuda Kollender, Josephine Issakov, et al.
Ear, Nose, & Throat Journal
|
July 29, 2025
How Far Can We Push the Limit in Palliative Surgery? A Case Report of Massive Chondroblastic Osteosarcoma of the Maxilla
Eiman Abu Bandora, Nariman Abd Elhadi, Sofi Matot, et al.
Gynecologic and Obstetric Investigation
|
September 20, 2007
The complexity of management of pregnancy-associated malignant soft tissue and bone tumors
Rinat Bernstein Molho, Yehuda Kollender, Josephine Issakov, et al.
The Oncologist
|
June 30, 2011
A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer
Neora Yaal-Hahoshen, Yair Maimon, Nava Siegelmann-Danieli, et al.
Cancer
|
June 24, 2023
Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer
Yasmin Leshem, Yardenna Dolev, Nava Siegelmann-Danieli, et al.
Targeted Oncology
|
September 9, 2014
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial
David F Heigener, José Rodrigues Pereira, Enriqueta Felip, et al.
Endocrine-Related Cancer
|
May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
David J Gross, Gabriel Munter, Menachem Bitan, et al.
Journal of Clinical Medicine
|
January 28, 2026
A Shift from Standard Median Sternotomy to Robotic-Assisted Thoracic Surgery for Resection of Anterior Mediastinal Tumors
Michael Peer, Sharbel Azzam, Nachum Nesher, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
BMC Cancer
|
July 2, 2020
Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
Sivan Shamai, Zach Rozenbaum, Ofer Merimsky, et al.
Journal of Thoracic Disease
|
April 16, 2026
Thoracoscopic lobectomy for early-stage non-small cell lung carcinoma: initial experience from a newly established Israeli center
Boris Giller, Sharbel Azzam, Nahum Nesher, et al.
Cancer Chemotherapy and Pharmacology
|
October 12, 2012
Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas
Rinat Bernstein-Molho, Yehuda Kollender, Josephine Issakov, et al.
Ear, Nose, & Throat Journal
|
July 29, 2025
How Far Can We Push the Limit in Palliative Surgery? A Case Report of Massive Chondroblastic Osteosarcoma of the Maxilla
Eiman Abu Bandora, Nariman Abd Elhadi, Sofi Matot, et al.
Gynecologic and Obstetric Investigation
|
September 20, 2007
The complexity of management of pregnancy-associated malignant soft tissue and bone tumors
Rinat Bernstein Molho, Yehuda Kollender, Josephine Issakov, et al.
The Oncologist
|
June 30, 2011
A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer
Neora Yaal-Hahoshen, Yair Maimon, Nava Siegelmann-Danieli, et al.
Cancer
|
June 24, 2023
Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer
Yasmin Leshem, Yardenna Dolev, Nava Siegelmann-Danieli, et al.
Targeted Oncology
|
September 9, 2014
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial
David F Heigener, José Rodrigues Pereira, Enriqueta Felip, et al.
Endocrine-Related Cancer
|
May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
David J Gross, Gabriel Munter, Menachem Bitan, et al.
Journal of Clinical Medicine
|
January 28, 2026
A Shift from Standard Median Sternotomy to Robotic-Assisted Thoracic Surgery for Resection of Anterior Mediastinal Tumors
Michael Peer, Sharbel Azzam, Nachum Nesher, et al.
Page
of 8